These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21709147)

  • 21. Heat production during anesthetic-induced malignant hyperthermia.
    Nelson TE
    Biosci Rep; 2001 Apr; 21(2):169-79. PubMed ID: 11725865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
    Monnier N; Lunardi J
    Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscular body build and male sex are independently associated with malignant hyperthermia susceptibility.
    Butala B; Brandom B
    Can J Anaesth; 2017 Apr; 64(4):396-401. PubMed ID: 28063098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant hyperthermia.
    McNeil B
    Br J Perioper Nurs; 2005 Sep; 15(9):376-7, 379-82. PubMed ID: 16178207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diseases associated with altered ryanodine receptor activity.
    Durham WJ; Wehrens XH; Sood S; Hamilton SL
    Subcell Biochem; 2007; 45():273-321. PubMed ID: 18193641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant hyperthermia.
    Bandschapp O; Girard T
    Swiss Med Wkly; 2012; 142():w13652. PubMed ID: 22851008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
    Muniz VP; Silva HC; Tsanaclis AM; Vainzof M
    J Mol Neurosci; 2003; 21(1):35-42. PubMed ID: 14500992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins.
    Nelson TE
    Curr Mol Med; 2002 Jun; 2(4):347-69. PubMed ID: 12108947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A noninvasive investigation of muscle energetics supports similarities between exertional heat stroke and malignant hyperthermia.
    Bendahan D; Kozak-Ribbens G; Confort-Gouny S; Ghattas B; Figarella-Branger D; Aubert M; Cozzone PJ
    Anesth Analg; 2001 Sep; 93(3):683-9. PubMed ID: 11524341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005.
    Rosero EB; Adesanya AO; Timaran CH; Joshi GP
    Anesthesiology; 2009 Jan; 110(1):89-94. PubMed ID: 19104175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant hyperthermia.
    Hopkins PM; Gupta PK; Bilmen JG
    Handb Clin Neurol; 2018; 157():645-661. PubMed ID: 30459030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant hyperthermia: a review.
    Golinski M
    Plast Surg Nurs; 1995; 15(1):30-3, 58. PubMed ID: 7777624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant hyperthermia.
    Dunn D
    AORN J; 1997 Apr; 65(4):728, 731, passim; quiz 755-8, 760-2. PubMed ID: 9093738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant hyperthermia].
    Metterlein T; Schuster F; Graf BM; Anetseder M
    Anaesthesist; 2014 Dec; 63(12):908-18. PubMed ID: 25384957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant hyperthermia: a pharmacogenetic disorder.
    Stowell KM
    Pharmacogenomics; 2008 Nov; 9(11):1657-72. PubMed ID: 19018722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesist; 1983 Apr; 32(4):141-57. PubMed ID: 6349413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology and Treatment of Malignant Hyperthermia.
    Gregory H; Weant KA
    Adv Emerg Nurs J; 2021 Apr-Jun 01; 43(2):102-110. PubMed ID: 33915557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant hyperthermia in China.
    Xu ZH; Luo AL; Guo XY; Ren HZ; Wang YL; Zhang X; Huang YG; Ye TH
    Anesth Analg; 2006 Oct; 103(4):983-5. PubMed ID: 17000816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant hyperthermia: a pharmacogenetic disorder.
    Stratman RC; Flynn JD; Hatton KW
    Orthopedics; 2009 Nov; 32(11):835. PubMed ID: 19902883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.